[144] Donaldson Company, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for proposed sale of 13,500 common shares valued at $1,066,871.25. The filing states the shares will be sold through Morgan Stanley Smith Barney LLC on the NYSE around 09/03/2025. The shares were acquired on 09/03/2025 by exercise of options under a registered plan and payment was in cash.

Certain identifying details are not provided in the document text supplied: the filer name/CIK and the issuer name/address fields are blank in the extract. The filer represents they are not aware of undisclosed material adverse information and certifies the accuracy of the notice by signature. No securities were reported sold by the filer during the past three months in this filing.

Positive

• Full transaction details provided: class, broker, number of shares, aggregate market value, exchange, and approximate sale date are listed
• Acquisition method disclosed: shares were acquired by exercise of options under a registered plan
• Broker identified: Morgan Stanley Smith Barney LLC is named to execute the sale
• Attestation included: filer represents no undisclosed material adverse information and acknowledges legal certification

Negative

• Missing filer identity: filer name and CIK are not present in the provided extract
• Missing issuer information: issuer name and address fields are blank in the supplied content
• Insufficient context to assess materiality: without filer/issuer identity, impact on shareholders or holdings cannot be evaluated

Insights

Securities Analyst

TL;DR: Routine Form 144 filing describing sale of exercised shares through a broker; no material adverse disclosure included.

The filing documents a proposed sale of 13,500 common shares acquired via option exercise and to be placed through Morgan Stanley Smith Barney LLC on the NYSE for an aggregate market value of $1,066,871.25. Acquisition and intended sale date are the same (09/03/2025), and payment was in cash. This is a standard Rule 144 notice for an insider or affiliate disposing of restricted or control securities. The absence of reported sales in the prior three months suggests this is an initial reported disposition in the recent period. The filing excerpt omits filer and issuer identifying details, limiting assessment of relative size or insider status.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; the filer certifies no undisclosed material adverse information but key identity fields are missing from the extract.

The form contains the required attestation about material information and references possible Rule 10b5-1 trading plans. It records the mechanics of acquisition (option exercise under a registered plan) and identifies the executing broker. From a governance perspective, the filing meets procedural disclosure of a proposed sale, but the provided extract lacks the filer and issuer names and CIK which are normally needed to evaluate insider status and potential governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13500	1066871.25	116519946	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2025	Exercise of options under a registered plan	Issuer			13500	09/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for DCI report?

The filing reports a proposed sale of 13,500 common shares with an aggregate market value of $1,066,871.25, to be sold via Morgan Stanley Smith Barney LLC on the NYSE around 09/03/2025.

How were the shares acquired according to the Form 144?

The shares were acquired on 09/03/2025 by exercise of options under a registered plan, and payment was made in cash.

Does the filing show prior sales by the filer in the past three months?

No. The section for securities sold during the past three months states Nothing to Report.

Is the broker for the transaction identified in the filing?

Yes. The filing names Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza as the broker.

Does the Form 144 include an attestation about material information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.